Display options
Cite
Alhossan A, Alrabiah Z, Alghadeer SM, et al. Satisfaction Levels concerning Current Chronic Constipation Treatment Options in Saudi Arabia. Gastroenterol Res Pract. 2020;2020:6545121doi: 10.1155/2020/6545121.
Alhossan, A., Alrabiah, Z., Alghadeer, S. M., Wajid, S., Al-Arifi, M. N., & Babelghaith, S. D. (2020). Satisfaction Levels concerning Current Chronic Constipation Treatment Options in Saudi Arabia. Gastroenterology research and practice, 20206545121. https://doi.org/10.1155/2020/6545121
Alhossan, Abdulaziz, et al. "Satisfaction Levels concerning Current Chronic Constipation Treatment Options in Saudi Arabia." Gastroenterology research and practice vol. 2020 (2020): 6545121. doi: https://doi.org/10.1155/2020/6545121
Alhossan A, Alrabiah Z, Alghadeer SM, Wajid S, Al-Arifi MN, Babelghaith SD. Satisfaction Levels concerning Current Chronic Constipation Treatment Options in Saudi Arabia. Gastroenterol Res Pract. 2020 Jan 02;2020:6545121. doi: 10.1155/2020/6545121. eCollection 2020. PMID: 32382268; PMCID: PMC7199577.
Copy Download .nbib Format: NLM
Share it on

Gastroenterol Res Pract. 2020 Jan 02;2020:6545121. doi: 10.1155/2020/6545121. eCollection 2020.

Satisfaction Levels concerning Current Chronic Constipation Treatment Options in Saudi Arabia.

Gastroenterology research and practice

Abdulaziz Alhossan, Ziyad Alrabiah, Sultan M Alghadeer, Syed Wajid, Mohamed N Al-Arifi, Salmeen D Babelghaith

Affiliations

  1. Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

PMID: 32382268 PMCID: PMC7199577 DOI: 10.1155/2020/6545121

Abstract

METHODS: This study was undertaken in Riyadh City, Saudi Arabia, in April 2019. The study population comprised respondents aged ≥18 years who had been recruited to participate through advertising on social media.

RESULTS: Of 532 respondents who completed our questionnaire, 153 (25.4%) had constipation, based on listed criteria, and of these, 121 (22.7%) reported having been constipated for ≥6 months; nearly 48% reported having been constipated for >3 years, while 63.6% of those chronically constipated were female. Bisacodyl was the laxative medication most used to treat chronic constipation, and 17.4% of users reported that they had used laxative medication for >12 months. Complementary and alternative medicines (CAMs) were utilized in 44.4% of respondents with chronic constipation. There was a significant association between the group who used CAMs and age (

Copyright © 2020 Abdulaziz Alhossan et al.

Conflict of interest statement

The authors declare that they have no conflicts of interest.

References

  1. BMC Gastroenterol. 2015 Oct 14;15:130 - PubMed
  2. Medicine (Baltimore). 2018 May;97(20):e10631 - PubMed
  3. Aliment Pharmacol Ther. 2007 Mar 1;25(5):599-608 - PubMed
  4. Aliment Pharmacol Ther. 2013 Jan;37(1):137-45 - PubMed
  5. Aliment Pharmacol Ther. 2004 Nov;20 Suppl 7:31-9 - PubMed
  6. Manag Care Interface. 2005 Aug;18(8):23-30 - PubMed
  7. J Family Med Prim Care. 2019 Feb;8(2):673-676 - PubMed
  8. Dig Dis Sci. 2011 Sep;56(9):2688-95 - PubMed
  9. Am J Gastroenterol. 2002 Aug;97(8):1986-93 - PubMed
  10. Pediatr Gastroenterol Hepatol Nutr. 2014 Dec;17(4):203-8 - PubMed
  11. Clin Gastroenterol Hepatol. 2009 May;7(5):502-8; quiz 496 - PubMed
  12. Aliment Pharmacol Ther. 2007 Jul 15;26(2):227-36 - PubMed
  13. Nat Rev Gastroenterol Hepatol. 2016 May;13(5):295-305 - PubMed
  14. J Neurogastroenterol Motil. 2011 Jul;17(3):245-51 - PubMed
  15. Neurogastroenterol Motil. 2011 Aug;23(8):697-710 - PubMed
  16. JAAPA. 2006 Nov;19(11):24-9 - PubMed

Publication Types